ES362648A1 - Un procedimiento para la preparacion de una composicion an-tibacteriana. - Google Patents
Un procedimiento para la preparacion de una composicion an-tibacteriana.Info
- Publication number
- ES362648A1 ES362648A1 ES362648A ES362648A ES362648A1 ES 362648 A1 ES362648 A1 ES 362648A1 ES 362648 A ES362648 A ES 362648A ES 362648 A ES362648 A ES 362648A ES 362648 A1 ES362648 A1 ES 362648A1
- Authority
- ES
- Spain
- Prior art keywords
- surface active
- coated
- active agent
- trihydrate
- particulate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 239000004094 surface-active agent Substances 0.000 abstract 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 abstract 3
- RXDALBZNGVATNY-CWLIKTDRSA-N ampicillin trihydrate Chemical compound O.O.O.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 RXDALBZNGVATNY-CWLIKTDRSA-N 0.000 abstract 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 239000004147 Sorbitan trioleate Substances 0.000 abstract 2
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 abstract 2
- 230000005660 hydrophilic surface Effects 0.000 abstract 2
- 235000011071 sorbitan monopalmitate Nutrition 0.000 abstract 2
- 239000001570 sorbitan monopalmitate Substances 0.000 abstract 2
- 229940031953 sorbitan monopalmitate Drugs 0.000 abstract 2
- 235000019337 sorbitan trioleate Nutrition 0.000 abstract 2
- 229960000391 sorbitan trioleate Drugs 0.000 abstract 2
- -1 sulphamyl Chemical group 0.000 abstract 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 abstract 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract 1
- RPWFJAMTCNSJKK-UHFFFAOYSA-N Dodecyl gallate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 RPWFJAMTCNSJKK-UHFFFAOYSA-N 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 abstract 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 abstract 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 235000010386 dodecyl gallate Nutrition 0.000 abstract 1
- 239000000555 dodecyl gallate Substances 0.000 abstract 1
- 229940080643 dodecyl gallate Drugs 0.000 abstract 1
- 238000001704 evaporation Methods 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 238000007918 intramuscular administration Methods 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- 229940067606 lecithin Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- 235000010981 methylcellulose Nutrition 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 125000005702 oxyalkylene group Chemical group 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- 239000003208 petroleum Substances 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 235000017281 sodium acetate Nutrition 0.000 abstract 1
- 239000001632 sodium acetate Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 235000002639 sodium chloride Nutrition 0.000 abstract 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
- 150000004684 trihydrates Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69869768A | 1968-01-18 | 1968-01-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES362648A1 true ES362648A1 (es) | 1971-07-16 |
Family
ID=24806316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES362648A Expired ES362648A1 (es) | 1968-01-18 | 1969-01-17 | Un procedimiento para la preparacion de una composicion an-tibacteriana. |
Country Status (12)
| Country | Link |
|---|---|
| AT (1) | AT284339B (en)) |
| BE (1) | BE727073A (en)) |
| DE (1) | DE1901915C3 (en)) |
| DK (1) | DK122930B (en)) |
| ES (1) | ES362648A1 (en)) |
| FI (1) | FI48040C (en)) |
| FR (1) | FR2000395A1 (en)) |
| GB (1) | GB1250714A (en)) |
| IE (1) | IE32959B1 (en)) |
| IL (1) | IL31431A (en)) |
| NL (1) | NL143423B (en)) |
| SE (1) | SE365409B (en)) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1532993A (en) * | 1975-03-07 | 1978-11-22 | Beecham Group Ltd | Injectable antibiotic compositions |
-
1969
- 1969-01-15 NL NL696900634A patent/NL143423B/xx not_active IP Right Cessation
- 1969-01-15 DE DE1901915A patent/DE1901915C3/de not_active Expired
- 1969-01-15 IL IL31431A patent/IL31431A/en unknown
- 1969-01-16 FI FI690127A patent/FI48040C/fi active
- 1969-01-16 DK DK22769AA patent/DK122930B/da not_active IP Right Cessation
- 1969-01-17 BE BE727073D patent/BE727073A/xx not_active IP Right Cessation
- 1969-01-17 SE SE00593/69A patent/SE365409B/xx unknown
- 1969-01-17 IE IE65/69A patent/IE32959B1/xx unknown
- 1969-01-17 ES ES362648A patent/ES362648A1/es not_active Expired
- 1969-01-17 FR FR6900790A patent/FR2000395A1/fr not_active Withdrawn
- 1969-01-17 GB GB1250714D patent/GB1250714A/en not_active Expired
- 1969-01-20 AT AT58769A patent/AT284339B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB1250714A (en)) | 1971-10-20 |
| DK122930B (da) | 1972-05-01 |
| DE1901915A1 (de) | 1969-09-11 |
| BE727073A (en)) | 1969-07-17 |
| DE1901915B2 (de) | 1979-12-13 |
| IE32959L (en) | 1969-07-18 |
| SE365409B (en)) | 1974-03-25 |
| IE32959B1 (en) | 1974-02-06 |
| AT284339B (de) | 1970-09-10 |
| FI48040C (fi) | 1974-06-10 |
| FR2000395A1 (en)) | 1969-09-05 |
| IL31431A (en) | 1973-05-31 |
| NL6900634A (en)) | 1969-07-22 |
| FI48040B (en)) | 1974-02-28 |
| DE1901915C3 (de) | 1980-08-21 |
| NL143423B (nl) | 1974-10-15 |
| IL31431A0 (en) | 1969-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2458576A1 (en) | Non-hardening clay composite and method for manufacturing same | |
| ES8106654A1 (es) | Procedimiento para la fabricacion de compuestos para el tra-tamiento del cancer | |
| CO4130326A1 (es) | Nuevos derivados de 2-ciano-1,3-diona, composiciones que los contienen, procedimientos para su preparacion y su uso como herbicidas | |
| DE68914110D1 (de) | Hämostastische Collagenpastenmaterialzusammensetzung. | |
| DE3222250A1 (de) | Pharmazeutische zubereitungen | |
| ES362648A1 (es) | Un procedimiento para la preparacion de una composicion an-tibacteriana. | |
| ES2063052T3 (es) | Aditivo suavizante de tejidos para composiciones de detergente. | |
| KR100888430B1 (ko) | 도배풀용 분말형 항균제 조성물과 이 항균제 조성물이혼합된 도배풀 | |
| DE2001127A1 (de) | Aerosolzubereitung zur Unterdrueckung der Transpiration | |
| US3681489A (en) | Method of forming films | |
| GB1560475A (en) | Pharmaceutical formulation | |
| US2977235A (en) | Water-soluble tablet for the curing of meat | |
| RU2022786C1 (ru) | Способ получения антисептика для пропитки древесины | |
| KR910019625A (ko) | 뼈의 무기질 소실을 억제하는 방법 | |
| DE1284684B (de) | Verfahren zur Herstellung fester Wirkstoff-Zubereitungen zur Bekaempfung von tierischen Schaedlingen in Wasser | |
| DE69904020T2 (de) | Pharmazeutische zusammensetzung zur nasalen verabreichung von thiocolchicosid | |
| DE1946277A1 (de) | Trockenmittel mit Feuchtigkeitsindikator | |
| DE2025593C3 (de) | Insektizides Mittel | |
| JPS6471439A (en) | Freshness retaining agent for fishes and shellfishes | |
| DE830992C (de) | Verfahren zur Herstellung von Aktivkohle enthaltenden Praeparaten | |
| AT204696B (de) | Absorber | |
| JPH0273001A (ja) | 速効性の改善された害虫用粉剤 | |
| DE2019658A1 (de) | Verfahren zur Herstellung eines Gleitmittels auf der Basis von Natriumbenzoat fuer loesliche Brausetabletten | |
| DE61035C (de) | Verfahren zur Förderung der Verbrennung von Brennstoffen unter Benutzung eines aus Natriumsulfat und Kaliumnitrat bestehenden Gemisches | |
| DE1492613C3 (de) | Verwendung einer Calciumsorbat-Suspension zur Tauchkonservierung von Lebensmitteloberflächen |